Vaxart, Inc. logo

Vaxart, Inc.

NASDAQ:VXRT

Overview | Financials
Company Name Vaxart, Inc.
Symbol VXRT
Currency USD
Price 0.358
Market Cap 81,953,005
Dividend Yield 0%
52-week-range 0.26 - 1.07
Industry Biotechnology
Sector Healthcare
CEO Mr. Cezar Andrei Floroiu M.B.A.
Website https://vaxart.com

An error occurred while fetching data.

About Vaxart, Inc.

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the

Related Stocks

Kinnate Biopharma Inc. logo

Kinnate Biopharma Inc.

KNTE

2.65 USD

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

0.72 USD

Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

PRAX

45.54 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

0.537 USD

IRadimed Corporation logo

IRadimed Corporation

IRMD

72.44 USD

RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc.

RAPT

11.38 USD

Nuvalent, Inc. logo

Nuvalent, Inc.

NUVL

76.58 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

7.51 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

3.42 USD

Financials

Numbers are in millions USD

Numbers are in millions USD